Lifetime health and economic benefits of weight loss among obese persons

被引:122
作者
Oster, G
Thompson, D
Edelsberg, J
Bird, AP
Colditz, GA
机构
[1] Policy Anal Inc, Brookline, MA 02445 USA
[2] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.2105/AJPH.89.10.1536
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. This study estimated the lifetime health and economic benefits of sustained modest weight loss among obese persons. Methods. We developed a dynamic model of the relationship between body mass index (BMI) and the risks and costs of 5 obesity-related diseases: hypertension, hypercholesterolemia, type 2 diabetes, coronary heart disease (CHD), and stroke. We then calculated the lifetime health and economic bens fits of a sustained 10% reduction in body weight for men and women aged 35 to 61 years with mild, moderate, and severe obesity. Results. Depending on age, gender, and initial BMI, a sustained 10% weight loss would(1) reduce the expected number of years of life with hypertension, hypercholesterolemia, and type 2 diabetes by 1.2 to 2.9, 0.3 to 0.8, and 0.5 to 1.7, respectively; (2) reduce the expected lifetime incidence of CHD and stroke by 12 to 38 cases per 1000 and 1 to 13 cases per 1000, respectively, (3) increase life expectancy by 2 to 7 months and (4) reduce expected lifetime medical care costs of these 5 diseases by $2200 to $5300. Conclusions. Sustained modest weight loss among obese persons would yield substantial health and economic benefits.
引用
收藏
页码:1536 / 1542
页数:7
相关论文
共 40 条
[11]   Long-term effects on plasma lipids of diet and drugs to treat hypertension [J].
Grimm, RH ;
Flack, JM ;
Grandits, GA ;
Elmer, PJ ;
Neaton, JD ;
Cutler, JA ;
Lewis, C ;
McDonald, R ;
Schoenberger, J ;
Stamler, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (20) :1549-1556
[12]   THE ECONOMIC COSTS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
HUSE, DM ;
OSTER, G ;
KILLEN, AR ;
LACEY, MJ ;
COLDITZ, GA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (19) :2708-2713
[13]   VARIABILITY OF BODY-WEIGHT AND HEALTH OUTCOMES IN THE FRAMINGHAM POPULATION [J].
LISSNER, L ;
ODELL, PM ;
DAGOSTINO, RB ;
STOKES, J ;
KREGER, BE ;
BELANGER, AJ ;
BROWNELL, KD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (26) :1839-1844
[14]  
MACMAHON SW, 1985, LANCET, V1, P1233
[15]  
*NAT CTR HLTH STAT, 1996, VIT STAT US 1992 B, V2
[16]   Cost of hypertension treatment [J].
Odell, TW ;
Gregory, MC .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1995, 10 (12) :686-688
[17]   Cholesterol-reduction intervention study (CRIS) - A randomized trial to assess effectiveness and costs in clinical practice [J].
Oster, G ;
Borok, GM ;
Menzin, J ;
Heyse, JF ;
Epstein, RS ;
Quinn, V ;
Benson, V ;
Dudl, RJ ;
Epstein, AM .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (07) :731-739
[18]   COST-EFFECTIVENESS OF TICLOPIDINE IN PREVENTING STROKE IN HIGH-RISK PATIENTS [J].
OSTER, G ;
HUSE, DM ;
LACEY, MJ ;
EPSTEIN, AM .
STROKE, 1994, 25 (06) :1149-1156
[19]   THE ECONOMIC COSTS OF SMOKING AND BENEFITS OF QUITTING FOR INDIVIDUAL SMOKERS [J].
OSTER, G ;
COLDITZ, GA ;
KELLY, NL .
PREVENTIVE MEDICINE, 1984, 13 (04) :377-389
[20]   PRIMARY PREVENTION AND CORONARY HEART-DISEASE - THE ECONOMIC-BENEFITS OF LOWERING SERUM-CHOLESTEROL [J].
OSTER, G ;
EPSTEIN, AM .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1986, 76 (06) :647-656